Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin-Gemcitabine with Radiotherapy in Inoperable Stage III NSCLC
NCT00192036Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2004
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in non-small cell lung cancer (NSCLC), sponsored by Eli Lilly and Company. Started Aug 2004; status: completed.
02
Drugs
gemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00192036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192036.